T2I
GSK icon

Turim 21 Investimentos’s GSK GSK Stock Holding History

Turim 21 Investimentos’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$21.2K Hold
404
– – ﹤0.01% 81
2026
Q1 		$22.3K Buy
+404
New +$21.9K 0.01% 72

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Turim 21 Investimentos's GSK Position: Q2 2026 in Review

Turim 21 Investimentos held its GSK (GSK) position steady in Q2 2026 at 404 shares worth $21.2K. The position accounts for ﹤0.01% of the portfolio, ranked #81.

Turim 21 Investimentos first reported a position in GSK in Q1 2026 and has held it in 2 quarters since. The position peaked at $22.3K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Turim 21 Investimentos held 404 shares of GSK worth $21.2K as of Q2 2026.
  • Turim 21 Investimentos left its GSK share count unchanged in Q2 2026.
  • GSK made up ﹤0.01% of Turim 21 Investimentos's portfolio in Q2 2026, its #81 holding.
  • Turim 21 Investimentos first reported a position in GSK in Q1 2026 and has held it in 2 quarters since.
  • Turim 21 Investimentos's GSK position peaked at $22.3K in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Turim 21 Investimentos's 13F filing for Q2 2026, filed 10 Aug 2026.